Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...

Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required ...

Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...

TUESDAY, Dec. 9, 2025 (HealthDay News) -- For patients with acute sickle cell disease (SCD) pain presenting to the emergency department (ED), guideline adherence for delivery of opioid pain ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

Cambridge-based Fulcrum Therapeutics said it will aim to launch a large clinical trial in the second half of 2026 to prove ...

Cellarity presented new preclinical data on investigational programs for sickle cell disease and myelofibrosis during the ASH Annual Meeting.

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

Scientific American hosted an event at Morehouse School of Medicine to highlight medical advances in treating sickle cell ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

Fulcrum Therapeutics stock surges on Monday after releasing positive results from Phase 1b trial of pociredir in sickle cell ...